Nature Medicine, Published online: 07 October 2025; doi:10.1038/s41591-025-03961-8
In the randomized phase 3 AMPLITUDE trial, patients with HRR-deficient mCSPC experienced longer progression-free survival when they were treated with niraparib and AAP compared to placebo and AAP.- October 7, 2025
- 0 Comment
Nature Medicine, Published online: 07 October 2025; doi:10.1038/s41591-025-03998-9
In this multicentered observational study, Rotavac, an indigenous, monovalent, live, attenuated, oral rotavirus vaccine, had an adjusted vaccine efficacy of 54% and protected against severe gastroenteritis in Indian children during its rollout between 2016 and 2020.- October 7, 2025
- 0 Comment
- October 6, 2025
- 0 Comment
Regulatory pressure and consumer demand are accelerating the phaseout of petroleum-based dyes—and the replacement process is far from a simple swap. From stability and sourcing to flavor impacts and cost, natural pigments require new strategies across formulation, labeling and supply chains.
- October 6, 2025
- 0 Comment
Nature Medicine, Published online: 06 October 2025; doi:10.1038/s41591-025-03971-6
In the double-blind, placebo-controlled phase 2 ARGO trial, patients with active psoriatic arthritis treated with a nanobody targeting IL-17A and IL-17F showed substantially better disease response rates compared with those receiving placebo treatment.- October 6, 2025
- 0 Comment
Nature Medicine, Published online: 06 October 2025; doi:10.1038/s41591-025-03983-2
This Review summarizes recent technical advancements in generative AI, outlines how new models might improve healthcare and discusses validation approaches—using lessons from recent successes and failures in the field.- October 6, 2025
- 0 Comment
Nature Medicine, Published online: 06 October 2025; doi:10.1038/s41591-025-04037-3
In a cross-trial analysis, combined treatment with medications that have individually shown to improve cardiovascular outcomes in heart failure with mildly reduced or preserved ejection fraction demonstrates substantial benefit, including for event-free survival.- October 6, 2025
- 0 Comment
Nature Medicine, Published online: 06 October 2025; doi:10.1038/s41591-025-03974-3
A modeling approach to assess the global risk of Plasmodium falciparum histidine-rich protein 2 and 3 gene deletions identifies ten priority African countries for surveillance and could inform malaria control policies.- October 6, 2025
- 0 Comment
- October 4, 2025
- 0 Comment
Nature Medicine, Published online: 02 October 2025; doi:10.1038/s41591-025-03978-z
A systematic review and meta-analysis of clinical trials investigating the efficacy and safety of obesity management medications reported tirzepatide and semaglutide to be the most effective in reducing body weight and obesity-related complications.- October 2, 2025
- 0 Comment